These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 29104057)
1. High payload nanostructured lipid carriers fabricated with alendronate/polyethyleneimine ion complexes. Abd El-Hamid BN; Swarnakar NK; Soliman GM; Attia MA; Pauletti GM Int J Pharm; 2018 Jan; 535(1-2):148-156. PubMed ID: 29104057 [TBL] [Abstract][Full Text] [Related]
2. Nanostructured lipid carriers with exceptional gastrointestinal stability and inhibition of P-gp efflux for improved oral delivery of tilmicosin. Zhang Q; Yang H; Sahito B; Li X; Peng L; Gao X; Ji H; Wang L; Jiang S; Guo D Colloids Surf B Biointerfaces; 2020 Mar; 187():110649. PubMed ID: 31767412 [TBL] [Abstract][Full Text] [Related]
3. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery. Li H; Chen M; Su Z; Sun M; Ping Q Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421 [TBL] [Abstract][Full Text] [Related]
4. Improved oral bioavailability of alendronate via the mucoadhesive liposomal delivery system. Han HK; Shin HJ; Ha DH Eur J Pharm Sci; 2012 Aug; 46(5):500-7. PubMed ID: 22522117 [TBL] [Abstract][Full Text] [Related]
5. Nanostructured lipid carriers used for oral delivery of oridonin: an effect of ligand modification on absorption. Zhou X; Zhang X; Ye Y; Zhang T; Wang H; Ma Z; Wu B Int J Pharm; 2015 Feb; 479(2):391-8. PubMed ID: 25556104 [TBL] [Abstract][Full Text] [Related]
6. Nanoscale Delivery of Resveratrol towards Enhancement of Supplements and Nutraceuticals. Neves AR; Martins S; Segundo MA; Reis S Nutrients; 2016 Mar; 8(3):131. PubMed ID: 26950147 [TBL] [Abstract][Full Text] [Related]
7. Development of nanostructured lipid carriers for the encapsulation and controlled release of vitamin D3. Park SJ; Garcia CV; Shin GH; Kim JT Food Chem; 2017 Jun; 225():213-219. PubMed ID: 28193417 [TBL] [Abstract][Full Text] [Related]
8. Alendronate-loaded microparticles for improvement of intestinal cellular absorption. Baek JS; Kwon HH; Hwang JS; Sung HC; Lee JM; Shin SC; Kim YR; Cho CW J Drug Target; 2011 Jan; 19(1):37-48. PubMed ID: 20477555 [TBL] [Abstract][Full Text] [Related]
9. The use of hot and cold high pressure homogenization to enhance the loading capacity and encapsulation efficiency of nanostructured lipid carriers for the hydrophilic antiretroviral drug, didanosine for potential administration to paediatric patients. Kasongo KW; Müller RH; Walker RB Pharm Dev Technol; 2012; 17(3):353-62. PubMed ID: 21241166 [TBL] [Abstract][Full Text] [Related]
10. G5-PEG PAMAM dendrimer incorporating nanostructured lipid carriers enhance oral bioavailability and plasma lipid-lowering effect of probucol. Qi R; Li YZ; Chen C; Cao YN; Yu MM; Xu L; He B; Jie X; Shen WW; Wang YN; van Dongen MA; Liu GQ; Banaszak Holl MM; Zhang Q; Ke X J Control Release; 2015 Jul; 210():160-8. PubMed ID: 26003044 [TBL] [Abstract][Full Text] [Related]
11. Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics. Chen CC; Tsai TH; Huang ZR; Fang JY Eur J Pharm Biopharm; 2010 Mar; 74(3):474-82. PubMed ID: 20060469 [TBL] [Abstract][Full Text] [Related]
12. Selection and characterization of suitable lipid excipients for use in the manufacture of didanosine-loaded solid lipid nanoparticles and nanostructured lipid carriers. Kasongo KW; Pardeike J; Müller RH; Walker RB J Pharm Sci; 2011 Dec; 100(12):5185-96. PubMed ID: 22020815 [TBL] [Abstract][Full Text] [Related]
13. Implications of formulation design on lipid-based nanostructured carrier system for drug delivery to brain. Salunkhe SS; Bhatia NM; Bhatia MS Drug Deliv; 2016 May; 23(4):1306-16. PubMed ID: 25080227 [TBL] [Abstract][Full Text] [Related]
14. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration. Song A; Zhang X; Li Y; Mao X; Han F Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734 [TBL] [Abstract][Full Text] [Related]
15. Cysteine-Functionalized Nanostructured Lipid Carriers for Oral Delivery of Docetaxel: A Permeability and Pharmacokinetic Study. Fang G; Tang B; Chao Y; Xu H; Gou J; Zhang Y; Xu H; Tang X Mol Pharm; 2015 Jul; 12(7):2384-95. PubMed ID: 25974386 [TBL] [Abstract][Full Text] [Related]
16. Strategies to enhance oral delivery of amphotericin B: a comparison of uncoated and enteric-coated nanostructured lipid carriers. Nimtrakul P; Sermsappasuk P; Tiyaboonchai W Drug Deliv; 2020 Dec; 27(1):1054-1062. PubMed ID: 32633144 [TBL] [Abstract][Full Text] [Related]
17. Enhanced intestinal absorption of curcumin in Caco-2 cell monolayer using mucoadhesive nanostructured lipid carriers. Chanburee S; Tiyaboonchai W J Biomed Mater Res B Appl Biomater; 2018 Feb; 106(2):734-741. PubMed ID: 28323388 [TBL] [Abstract][Full Text] [Related]
18. Repaglinide-loaded nanostructured lipid carriers with different particle sizes for improving oral absorption: preparation, characterization, pharmacokinetics, and Wu L; Zhao L; Su X; Zhang P; Ling G Drug Deliv; 2020 Dec; 27(1):400-409. PubMed ID: 31729898 [TBL] [Abstract][Full Text] [Related]
19. Solid lipid nanocarriers diffuse effectively through mucus and enter intestinal cells - but where is my peptide? Dumont C; Beloqui A; Miolane C; Bourgeois S; Préat V; Fessi H; Jannin V Int J Pharm; 2020 Aug; 586():119581. PubMed ID: 32603838 [TBL] [Abstract][Full Text] [Related]
20. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Das S; Ng WK; Tan RB Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]